• share
• favorite_border

TAMPA, Fla. - A new study published in Cell Press reveals critical insights into the role of gamma-delta T cells across 33 cancer types, shedding light on their potential as clinical biomarkers and therapeutic targets in cancer treatment. Led by a team of researchers at Moffitt Cancer Center, this comprehensive analysis represents a significant advancement in the understanding of these unique immune cells and their implications for patient outcomes in cancer therapy.

• share
• favorite_border

Houston Methodist researchers will be part of a national consortium funded by an up to $49 million award from the U.S. Government鈥檚 Advanced Research Projects Agency for Health (ARPA-H) to develop a vaccine against two of the most common and destructive strains of herpesviruses that latently infect a majority of Americans and can lead to acute infections, multiple forms of cancer, autoimmune disease and birth defects.

• share
• favorite_border

The question isn鈥檛 if, but when, the next pandemic will hit. Research and observation have identified strong potential for the next pandemic-causing virus to come from one or more of five different virus families.

• share
• favorite_border

The 2025 recipient of the American Society for Investigative Pathology (ASIP) Frieda Robscheit-Robbins Award for Exceptional Achievement in the Advancement of Women in Experimental Pathology is Dr. Martha B. Furie, Professor of Pathology, Microbiology, and Immunology in the School of Medicine at Stony Brook University.

• share
• favorite_border

The 2025 recipient of the American Society for Investigative Pathology (ASIP) Rous-Whipple Award is Dr. Anindya Dutta, Endowed Professor and Chair of the Department of Genetics at the University of Alabama 鈥� Birmingham.

• share
• favorite_border

he 2025 recipient of the American Society for Investigative Pathology (ASIP) Outstanding Investigator Award is Dr. Pilar Alcaide, Kenneth and Jo Ann G. Wellner Professor, Director of Tufts Immunology Graduate Program, and Assistant Dean for Faculty Development in the Department of Immunology at the Tufts University School of Medicine.

• share
• favorite_border

The 2025 recipient of the American Society for Investigative Pathology (ASIP) Gold-Headed Cane Award is Dr. Fred P. Sanfilippo, Professor of Pathology and Laboratory Medicine, Professor of Health Policy and Management, and Director of the Emory-Georgia Tech Healthcare Innovation Program at the Emory University School of Medicine.

• share
• favorite_border

The 2025 recipient of the American Society for Investigative Pathology (ASIP) Robbins Distinguished Educator Award is Dr. Dani S. Zander, MacKenzie Professor and Chair in the Department of Pathology and Laboratory Medicine at the University of Cincinnati College of Medicine.

• share
• favorite_border

The 2025 recipient of the American Society for Investigative Pathology (ASIP) Young Scientist Leadership Award is Dr. Nakisha S. Rutledge, a Postdoctoral Fellow in the Prizker School of Molecular Engineering at the Chicago Immunoengineering Innovation Center, University of Chicago.

• share
• favorite_border

• share
• favorite_border

A new study led by researchers at Johns Hopkins Bloomberg School of Public Health estimates that thousands of lives could have been saved during the first year of the COVID-19 pandemic if convalescent plasma had been used more broadly, particularly in outpatients at high risk for severe disease and in hospitalized patients during their first few days of admission.

• share
• favorite_border

Mayo Clinic is the prime site for an ARPA-H award to develop an implantable device that acts as a living pharmacy, triggering a "cell factory" in the body to treat inflammatory disease. ARPA-H, short for Advanced Research Projects Agency for Health, is an agency within the Department of Health and Human Services. It supports research for potentially transformative biomedical and health breakthroughs.

• share
• favorite_border

The University of Texas MD Anderson Cancer Center鈥檚 Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson鈥檚 world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.

• share
• favorite_border

A Cleveland Clinic-led research collaboration between Timothy Chan, MD, PhD, Chair of Cleveland Clinic鈥檚 Global Center for Immunotherapy, and Bristol Myers Squibb has published the most comprehensive overview to date of how our immune system reshapes tumor architecture in response to immune checkpoint therapy. The eight-year study, published in Nature Medicine, outlines how cancer immunotherapy induces tumor recognition through neoantigens to reshape the tumor ecosystem.

• share
• favorite_border

The complex shape of respiratory syncytial virus is one hurdle limiting the development of treatments for an infection that leads to hospitalization or worse for hundreds of thousands of people in the United States each year, according to the Centers for Disease Control and Prevention. New images of the virus from researchers at the University of Wisconsin鈥揗adison may hold the key to preventing or slowing RSV infections.

• share
• favorite_border

September usually marks the start of flu season, and with the ongoing threat of COVID-19, it鈥檚 crucial to be vigilant about your family鈥檚 health. The challenge, however, is being able to tell the difference between the flu, the common cold, respiratory syncytial virus (RSV) and COVID-19, since all have similar symptoms.

• share
• favorite_border

New findings on how past viral respiratory infections affect future, unrelated ones could lead to therapies for boosting general antiviral immunity鈥攁nd potentially better pandemic preparedness.

• share
• favorite_border